Bennu samples reveal biological sugars, a strange, gum-like material, and ancient stardust that shed light on the early solar ...

Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute ...

Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been ...

Kihealth, Inc., a precision diagnostics company transforming how chronic and metabolic diseases are detected, today announced it has been selected as the 2025 KidsX Pediatric Innovation People's ...

Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease ...

The tiny pantheon known as the Asgard archaea bear traits that hint at how plants, animals and fungi emerged on Earth.

If you are wondering whether Natera’s soaring share price still leaves room for upside, or if the easy money has already been made, you are in the right place to unpack what the market is really ...

Everyone talks about turmeric and salmon when discussing anti-inflammation. You've heard it all before. Maybe you're tired of ...

A new study shows that some widely used BPA replacements can kill cells and disrupt key functions, prompting scientists to ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

Challenging federal funding cuts, minimal residual disease, and a busy field of CAR T-cell candidates characterized this year ...